- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07248241
Developing and Evaluating a Digital Intervention Aiming to Support Informal Caregivers of People With Dementia
The Caregiver Education Resource for Dementia (CARE-Dem) Study: Developing and Evaluating a Digital Intervention to Support Informal Caregivers of People With Dementia
The goal of this feasibility trial is to test the acceptability and feasibility of a new digital education pro-gram, the Caregiver Education Resource for Dementia (CARE-Dem). This is a behavioral (non-medical) intervention, designed to support informal caregivers of people with dementia. The primary purpose is to explore whether this program can help improve wellbeing and reduce burden among informal caregivers. The study focuses on adult caregivers, such as spouses, partners, relatives, or close friends of people recently diagnosed with dementia or living with mild dementia.
The main questions it aims to answer are:
- Is it possible to recruit and retain caregivers to participate in this type of digital intervention?
- Do participants find the program relevant, useful, and acceptable? Are the study procedures and outcome measures (such as questionnaires) suitable and manage-able for the participants?
- Does the intervention show preliminary signs of reducing caregiver burden and improving care-givers' wellbeing, knowledge, quality of relationship with the person with dementia, ability to ac-cept the situation, and feelings of being capable of managing their caregiving role? Researchers will compare caregivers who receive the CARE-Dem program with a control group who are offered the usual municipal information sessions. This allows us to see whether the digital pro-gram is feasible and whether it shows signs of effect compared with standard practice.
Participants in the intervention group will be asked to:
• Use the CARE-Dem digital platform over a three-month period.
The platform includes three modules:
Module 1: Understanding dementia and medical treatment options Module 2: Everyday life and communication with a person with dementia Module 3: Legal and practical matters, and information on support available in the community
- Engage with a mix of learning materials such as short videos, fact sheets, interactive activities, guides, and links to further resources
- Complete questionnaires at baseline and after 3 months to measure caregiver burden, wellbeing, and self-efficacy
- Take part in qualitative interviews about their experiences with the program, including usability, satisfaction, acquired knowledge, benefits, and suggestions for improvement.
Participants in the control group will receive treatment as usual. They will be offered to take part in existing information sessions provided by the municipalities, but attendance is optional. Researchers will record whether or not they attend, in order to compare results across subgroups.
This feasibility trial will help determine whether it is possible to run a larger evaluation of the CARE-Dem program in the future. If successful, the program could provide flexible and accessible support to the many caregivers of people with dementia, reaching those who cannot attend traditional in-person sessions.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julie C Grew, PhD
- Phone Number: +4526285755
- Email: julie.grew@regionh.dk
Study Contact Backup
- Name: Elise H Christensen, PhD
- Phone Number: +45 23 82 23 59
- Email: elise.harder.christensen@regionh.dk
Study Locations
-
-
-
Frederiksberg, Denmark, 2000
- Department of Geriatrics and Palliation, University Hospital Bispebjerg and Frederiksberg ty Hospital
-
Contact:
- Kristina D Munk
- Phone Number: +4520304299
- Email: kristina.due.munk@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult family members/relatives/other adult informal caregivers of a newly diagnosed person with dementia/a person with mild dementia
Exclusion Criteria:
- Unable to speak/understand Danish
- Incapable of collaborating about signing the informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Participants receive the CARE-Dem intervention
|
The CARE-Dem digital support tool offers a number of modules that participants must complete within three months.
|
|
No Intervention: Control group
Participants receive treatment as usual and can use available offers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment rate
Time Frame: Baseline minus three months (start of enrollment) to baseline
|
Number of participants enrolled divided by number of eligible individuals.
Registered by a project nurse at the recruiting clinic
|
Baseline minus three months (start of enrollment) to baseline
|
|
Response rate to survey
Time Frame: Three months (end of intervention)
|
Number of full surveys returned at follow-up divided by total number of participants.
Assessed in the REDCap database where all survey data are gathered.
|
Three months (end of intervention)
|
|
User experiences with intervention
Time Frame: Three months (end of intervention)
|
Satisfaction, relevance, perceived value, ease of use, key barriers and facilitators for use, suggestions for improvement of the CARE-Dem.
Assessed through semi-structured, qualitative interviews with participants in the intervention group.
|
Three months (end of intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barriers to recruitment
Time Frame: Baseline minus three months (start of enrolment) to baseline
|
Assessed through semi-structured, qualitative interviews with all professionals involved in re-cruitment and randomisation.
|
Baseline minus three months (start of enrolment) to baseline
|
|
Completeness of survey data
Time Frame: Three months (end of intervention)
|
Number of completed survey items at follow-up divided by total number of items.
Only surveys filled in at baseline and end of intervention are counted.
Assessed in the REDCap database where all survey data are gathered.
|
Three months (end of intervention)
|
|
Relevance of outcome measures to the target population
Time Frame: Three months (end of intervention)
|
Assessed through semi-structured, qualitative interviews with all participants in the intervention group.
|
Three months (end of intervention)
|
|
Extent to which the selected outcome measures demonstrate changes in the expected direction and magnitude
Time Frame: Three months (end of intervention)
|
Evaluated by comparing observed mean change scores from baseline to end of intervention with effect sizes reported in previous studies of digital interventions for informal caregivers of people with dementia.
Feasibility will be considered acceptable if observed changes in the intervention group from baseline to end of intervention are in the expected direction and within the range of small-to-moderate effects (Cohen's d ≥ 0.20), consistent with similar studies of digital interventions for informal caregivers of people with dementia.
|
Three months (end of intervention)
|
|
Experiences of randomisation procedure
Time Frame: Baseline
|
Assessed via short interviews with recruiting nurses who collect accounts from participants in the intervention group and participants in the control group.
|
Baseline
|
|
Reasons for non-adherence and dropout
Time Frame: Three months (end of intervention)
|
Assessed through interviews with participants who do not complete the intervention within the designated three months.
We aim to interview as many as possible among participants who drop out or do not complete the intervention.
|
Three months (end of intervention)
|
|
Intervention dose received
Time Frame: Three months (end of intervention)
|
Proportion of intervention components completed by each participant within three months.
Collected via participant logs, where all interaction with the intervention will be documented by participants in the intervention group.
|
Three months (end of intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in caregiver burden from baseline to end of intervention
Time Frame: Baseline and three months
|
Measured with the Zarit Burden Interview (ZBI), a 22-item questionnaire including four aspects of caregiver burden: personal strain, role strain, impact on social life, and impact on personal health.
Items are rated on a 5-point Likert scale ranging from 0 (never) to 4 (nearly always) with total scores ranging from 0 to 88.
|
Baseline and three months
|
|
Change in mental wellbeing from baseline to end of intervention
Time Frame: Baseline and three months
|
Measured with the World Health Organization 5-Item Well-Being Index (WHO-5), a 5-item ques-tionnaire concerning feelings about everyday life in the previous two weeks.
Items are rated on a 6-point Likert scale ranging from 0 (at no time) to 5 (all the time).
The raw score ranges from 0 to 25 and is converted to a percentage score from 0 to 100.
|
Baseline and three months
|
|
Change in self-efficacy from baseline to end of intervention
Time Frame: Baseline and three months
|
Measured with the General Self-Efficacy Scale (GSES), a 10-item questionnaire assessing per-ceived ability to cope with challenging and demanding situations.
Items are rated on a 4-point Lik-ert scale from 1 (not at all true) to 4 (exactly true) with total scores ranging from 10 to 40.
|
Baseline and three months
|
|
Acquired knowledge and benefit of the intervention
Time Frame: Three months (end of intervention)
|
Participants' experiences of knowledge and benefits acquired from using the intervention, particularly regarding impact on the quality of their relation to the person with dementia, experiences of being able to accept the situation, and feelings of being capable of managing their caregiving role.
Assessed through qualitative interviews with participants in the intervention group.
|
Three months (end of intervention)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CARE-Dem
- J.nr. 2024-0040 (Other Grant/Funding Number: Region Hovedstadens Forskningsfond til Sundhedsforskning)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia Caregiver
-
The University of Hong KongNot yet recruiting
-
Education University of Hong KongThe University of Hong Kong; Columbia University; The Hong Kong Polytechnic University and other collaboratorsNot yet recruiting
-
Milton S. Hershey Medical CenterNYU Langone Health; National Institute on Aging (NIA)Not yet recruitingDementia | Caregiver Burden | Caregiver Stress | Caregiver Burden of People With DementiaUnited States
-
Rendever, Inc.National Institute on Aging (NIA); RANDRecruitingDementia Caregiver | Peer Support | Caregiver Social Support | Direct Care Workers | In-Home CareUnited States
-
Emory UniversityNational Institute on Aging (NIA)Completed
-
Massachusetts General HospitalCompleted
-
VA Office of Research and DevelopmentTerminatedDementia Family Caregiver Burden and ConflictUnited States
-
University of Southern CaliforniaCalifornia Department of Public HealthRecruitingCaregiver Burden of People With DementiaUnited States
-
University of RostockGerman Center for Neurodegenerative Diseases (DZNE)Completed
-
Hülya Nuray BayraktarHacettepe UniversityCompletedHealthy | Caregiver Burden | Self Efficacy | Caregiver | Caregiver Stress | Caregiver Burden of People With DementiaTurkey
Clinical Trials on Digital support tool
-
University of FloridaFogarty International Center of the National Institute of HealthRecruitingTelemedicine | PediatricsHaiti
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
London School of Economics and Political ScienceWysaCompletedWellbeing | Self Efficacy | Resilience | Problem Solving | Life SkillsIndia
-
Jonkoping UniversityCompletedBreast CancerSweden
-
Lund UniversityUniversity of California, San Diego; PainDrainer ABCompleted
-
Karolinska InstitutetRegion StockholmCompleted
-
Hospital del MarUnknown
-
WysaImperial College London; Wellcome Trust; Tata Institute of Social Sciences; Milaan...Not yet recruitingAnxiety | Depression in Adolescence | Anxiety Disorder of Adolescence
-
Dana-Farber Cancer InstituteHyundai Hope On WheelsNot yet recruitingSarcoma | Acute Myeloid Leukemia | Osteosarcoma | Ewing Sarcoma | Medulloblastoma | Aml | Rhabdomyosarcoma | ALL | Acute Lymphoblastic Leukemia ,LymphomasUnited States
-
Lund UniversityNewton-Wellesley HospitalCompleted